Reference:
1. Wilby KJ, Johnson EG, Johnson HE and Ensom MHH. Evidence-based review of pharmacotherapy used for parkinson’s disease psychosis. Ann Pharmacother 2017;51:682-95.
2. Zahodne LB, Fernandez HH. A review of the pathophysiology and treatment of psychosis in parkinson’s disease. Drugs Aging 2008;25:665-82.
3. Mohr E, Mendis T, Hildebrand K and De Deyn PP. Risperidone in the treatment of dopamine induced psychosis in parkinson’s disease: an open pilot trial. Mov Disord 2000;15:1230-7.
Keywords:
-